vs
Side-by-side financial comparison of Eastern Bankshares, Inc. (EBC) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
Eastern Bankshares, Inc. is the larger business by last-quarter revenue ($295.9M vs $185.2M, roughly 1.6× AMICUS THERAPEUTICS, INC.). Eastern Bankshares, Inc. runs the higher net margin — 22.1% vs 0.9%, a 21.2% gap on every dollar of revenue. On growth, Eastern Bankshares, Inc. posted the faster year-over-year revenue change (710.6% vs 23.7%). Over the past eight quarters, Eastern Bankshares, Inc.'s revenue compounded faster (38.6% CAGR vs 29.5%).
Eastern Bank is a bank based in Boston, Massachusetts. Before de-mutualizing in 2020, it was the oldest and largest mutual bank in the United States and the largest community bank in Massachusetts.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
EBC vs FOLD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.9M | $185.2M |
| Net Profit | $65.3M | $1.7M |
| Gross Margin | — | 85.7% |
| Operating Margin | — | 8.6% |
| Net Margin | 22.1% | 0.9% |
| Revenue YoY | 710.6% | 23.7% |
| Net Profit YoY | -34.4% | -88.5% |
| EPS (diluted) | $0.29 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $295.9M | — | ||
| Q4 25 | $37.5M | $185.2M | ||
| Q3 25 | $241.5M | $169.1M | ||
| Q2 25 | $244.9M | $154.7M | ||
| Q1 25 | $31.1M | $125.2M | ||
| Q4 24 | $216.5M | $149.7M | ||
| Q3 24 | $203.4M | $141.5M | ||
| Q2 24 | $154.0M | $126.7M |
| Q1 26 | $65.3M | — | ||
| Q4 25 | $99.5M | $1.7M | ||
| Q3 25 | $106.1M | $17.3M | ||
| Q2 25 | $100.2M | $-24.4M | ||
| Q1 25 | $-217.7M | $-21.7M | ||
| Q4 24 | $60.8M | $14.7M | ||
| Q3 24 | $-6.2M | $-6.7M | ||
| Q2 24 | $26.3M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 85.7% | ||
| Q3 25 | — | 88.5% | ||
| Q2 25 | — | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | — | 90.1% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 91.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 8.6% | ||
| Q3 25 | 38.9% | 20.3% | ||
| Q2 25 | 41.0% | -6.1% | ||
| Q1 25 | -590.9% | -6.3% | ||
| Q4 24 | 33.3% | 10.7% | ||
| Q3 24 | -1.6% | 15.3% | ||
| Q2 24 | 24.7% | 11.8% |
| Q1 26 | 22.1% | — | ||
| Q4 25 | 265.6% | 0.9% | ||
| Q3 25 | 44.0% | 10.2% | ||
| Q2 25 | 40.9% | -15.8% | ||
| Q1 25 | -699.2% | -17.3% | ||
| Q4 24 | 28.1% | 9.8% | ||
| Q3 24 | -3.0% | -4.8% | ||
| Q2 24 | 17.1% | -12.4% |
| Q1 26 | $0.29 | — | ||
| Q4 25 | $0.48 | $0.00 | ||
| Q3 25 | $0.53 | $0.06 | ||
| Q2 25 | $0.50 | $-0.08 | ||
| Q1 25 | $-1.08 | $-0.07 | ||
| Q4 24 | $0.29 | $0.05 | ||
| Q3 24 | $-0.03 | $-0.02 | ||
| Q2 24 | $0.16 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $551.7M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $4.3B | $274.2M |
| Total Assets | $30.6B | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $551.7M | — | ||
| Q4 25 | $507.6M | $293.5M | ||
| Q3 25 | $703.4M | $263.8M | ||
| Q2 25 | $948.3M | $231.0M | ||
| Q1 25 | $609.0M | $250.6M | ||
| Q4 24 | $1.9B | $249.9M | ||
| Q3 24 | $1.7B | $249.8M | ||
| Q2 24 | $1.4B | $260.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $274.2M | ||
| Q3 25 | $3.8B | $230.4M | ||
| Q2 25 | $3.7B | $204.3M | ||
| Q1 25 | $3.6B | $193.6M | ||
| Q4 24 | $3.6B | $194.0M | ||
| Q3 24 | $3.7B | $178.8M | ||
| Q2 24 | $3.0B | $132.5M |
| Q1 26 | $30.6B | — | ||
| Q4 25 | $30.6B | $949.9M | ||
| Q3 25 | $25.5B | $868.8M | ||
| Q2 25 | $25.5B | $815.3M | ||
| Q1 25 | $25.0B | $789.8M | ||
| Q4 24 | $25.6B | $785.0M | ||
| Q3 24 | $25.5B | $786.6M | ||
| Q2 24 | $21.0B | $749.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $16.3M |
| Free Cash FlowOCF − Capex | — | $16.0M |
| FCF MarginFCF / Revenue | — | 8.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | — | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $432.4M | $16.3M | ||
| Q3 25 | $157.1M | $35.7M | ||
| Q2 25 | $123.9M | $-26.5M | ||
| Q1 25 | $47.3M | $7.8M | ||
| Q4 24 | $283.8M | $-3.9M | ||
| Q3 24 | $108.3M | $-23.0M | ||
| Q2 24 | $54.3M | $22.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $16.0M | ||
| Q3 25 | — | $35.3M | ||
| Q2 25 | — | $-28.9M | ||
| Q1 25 | — | $7.5M | ||
| Q4 24 | — | $-4.2M | ||
| Q3 24 | — | $-23.3M | ||
| Q2 24 | — | $21.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 8.6% | ||
| Q3 25 | — | 20.9% | ||
| Q2 25 | — | -18.7% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | -2.8% | ||
| Q3 24 | — | -16.5% | ||
| Q2 24 | — | 17.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.9% |
| Q1 26 | — | — | ||
| Q4 25 | 4.35× | 9.62× | ||
| Q3 25 | 1.48× | 2.06× | ||
| Q2 25 | 1.24× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.67× | -0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.06× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EBC
Segment breakdown not available.
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
